Related Experiment Videos
Topical tacrolimus and pimecrolimus: future directions.
1Emory University School of Medicine, Atlanta, GA, USA.
Seminars in Cutaneous Medicine and Surgery
|January 5, 2002
Summary
Topical immunomodulators, like tacrolimus ointment and pimecrolimus cream, are effective for atopic dermatitis. Their safety and anti-inflammatory properties suggest potential for treating other skin conditions such as psoriasis.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Topical immunomodulators, including tacrolimus ointment and pimecrolimus cream, are a novel class of drugs.
- These agents were initially developed for treating atopic dermatitis.
- Their favorable safety and anti-inflammatory profiles present opportunities for broader dermatological applications.
Purpose of the Study:
- To review the published literature on the use of topical immunomodulators beyond atopic dermatitis.
- To explore the efficacy of these agents in treating various other skin disorders.
- To discuss potential future modifications and novel applications of topical immunomodulators.
Main Methods:
- Systematic review of published studies.
- Analysis of clinical experiences with topical tacrolimus and pimecrolimus.
- Literature search for applications in psoriasis, seborrheic dermatitis, lichen planus, pyoderma gangrenosum, and other dermatoses.
Main Results:
- Topical immunomodulators have demonstrated efficacy in treating conditions such as psoriasis, seborrheic dermatitis, and lichen planus.
- Published data supports their use as anti-inflammatory agents in various dermatological diseases.
- The safety profile remains a key advantage across different applications.
Conclusions:
- Topical immunomodulators possess significant therapeutic potential for a range of skin disorders beyond atopic dermatitis.
- Further research into modified compounds and novel applications is warranted.
- These agents represent a valuable addition to the dermatological treatment armamentarium.